As a Network we are committed to taking action to address opioid misuse with the following resources.

ATTC Educational Packages For Opioid Use Disorders

Training Curricula and Slides

• Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals
• Buprenorphine: Short-term Opioid Withdrawal Using Buprenorphine
• Buprenorphine Treatment for Young Adults
• Heroin, Prescription Opioids, and HIV: What Clinicians Need to Know
• Medication-Assisted Treatment (MAT) for Substance Use Disorders: A Summit for Kansas & Missouri: Presentation Handouts
• Prescription Opioid Treatment Study (POATS)

Online Courses

• Substance Use Disorder Basics: Understanding Substance Use Disorders
• Essential Substance Abuse Skills: Foundations for Working with Addictions
• Supporting Recovery with Medications for Addiction Treatment (MAT)
• Supporting Recovery with Medications for Addiction Treatment (MAT) for Medical Professionals
• Get Naloxone Now

Recorded Webinars, Toolkits and Other Resources

• Opioid Prescribers Series: Adopting Guidelines for Opioid Prescribing in Primary Care
• CA Hub and Spoke System: MAT Expansion Project
• Developing a Collaborative Approach to Address the Opioid Epidemic (from the ATTC PPW CoE)
• Fentanyl-The Fatal Fentanyl: From China to American Small Town
• InfoDeck: Addressing Prescription Opioid Misuse/Overdose Issues in Rural Areas
  
• Introduction to Opioids & Medication-assisted Treatment
• Medication-Assisted Treatment Fact Sheets
  
• Medications for Addiction Treatment (MAT) Resource Library
• Medication-Assisted Treatment: Six Module Training Series
• Medication-Assisted Treatment for Opioid Addiction in a Criminal Justice Context: Implementation Brief
• Opioid Patient Education Handout: English
• Opioid Patient Education Handout: Spanish
• Opioid Prescribing: Safe Practice, Changing Lives
• Opioid Related Role Play for a Referral to Treatment Using the SBIRT Model
• Opioid Use Disorders in Hispanic and Latinos Living in the United States
• Patient-centered Care in Opioid Treatment Programs
• ROSC and Medicated Assisted Treatment - Part 1
• ROSC and Medicated Assisted Treatment - Part 2
• SBIRT: Talking About SBIRT for Adolescents: An Upstream Invervention to Address the Heroin and Prescription Opioid Epidemic
• Strategies to Address Opioid and Prescription Drug Abuse
• Syndemics Part 1: What Addiction Treatment Providers Need to Know About HIV and Viral Hepatitis
• Treating Women for Opioid Use Disorder During Pregnancy: Methadone and Buprenorphine as Part of a Complete Care Approach
• Tribal Prescription Drug Abuse Summit: Moving from Information Sharing to Action Plan

ATTC Products

• Addressing Prescription Opioid Misuse/Overdose Issues in Rural Areas
• Alternatives to Using Opioids for Pain Management
• Buprenorphine Treatment for Young Adults
• Developing a Collaborative Approach to Address the Opioid Epidemic
• Factsheet: Opioid Use Disorders in Hispanic and Latinos living in the United States
• Heroin, Prescription Opioids, and HIV: What Clinicians Need to Know
• Hoja Informativa #1 de ATM: Asegurando la Aceptación
• Hoja Informativa #2: Reduciendo el Riesgo de Uso Indebido y la Desviación
• Hoja Informativa #3: Abogando por los Medicamentos
• Hot Topic: Opioid Prescribing: Safe Practice, Changing Lives
• Improving the Quality and Outcomes of Buprenorphine Treatment
• In My Own Words... Essay Booklet (2011) - A compilation of essays by individuals supported by Medication-Assisted Treament in long-term recovery
• Management of Benzodiazepenes in Medication-Assisted Treatment
• Management of Opioid Use Disorder in Primary Care (Webinar)
• MAT Training Series: Module I - Opioid Addiction & Treatment: Understanding the Disorder, Treatment and Protocol
• MAT Training Series: Module II - Opioids 101
• MAT Training Series: Module III - Medications 101
• MAT Training Series: Module IV: Identification of Patients for Medication Assisted Treatment
• Medication Assisted Treatment in the Criminal Justice System
• Medication-Assisted Treatment Fact Sheet #1: Securing Buy-in
• Medication-Assisted Treatment Fact Sheet #2: Diversion
• Medication-Assisted Treatment Fact Sheet #3: Why MAT?
• Medication-Assisted Treatment for Opioid Addiction in a Criminal Justice Context:An Implementation Brief for Community Supervision
• Medication-Assisted Treatment in Community Corrections Settings
• Medications for Addiction Treatment
• Narcotics Anonymous and the Pharmacotherapeutic Treatment of Opioid Addiction in the United States
• Opioid Addiction and Abuse in Primary Care Practice: A Comparison of Methadone and Buprenorphine as Treatment Options
• Opioid Prescribers' Series: Adopting Guidelines for Opioid Prescribing in Primary Care
• Patient-Centered Care in Opioid Treatment Programs (Webinar)
• Prescription Opioid Addiction Treatment Study (POATS) Training Materials
• Prescription Opioids 101: What HIV Clinicians Need to Know
• Prescription Opioids and Heroin Patient Education
• Prescription Opioids and Heroin Patient Education (Spanish)
• Short-Term Opioid Withdrawal Using Buprenorphine
• Simplifying MAT: Medication -Assisted Treatment in Arizona
• Strategies to Address Opioid and Prescription Drug Misuse
• Supporting Recovery with Medications for Addiction Treatment (MAT)
• Supporting Recovery with Medications for Addiction Treatment (MAT) for Medical Professionals
• Surgeon General Advisory on Naloxone and Opioid Overdose
• Taking Action to Address Opioid Misuse
• The Use of Buprenorphine in Treating Opioid Dependence
• Tiffany Role Play: Alcohol, Opioids, Referral to Treatment
• Treating Women for Opioid Use Disorder during Pregnancy: Methadone and Buprenorphine as a Part of a Complete Care Approach
• Treatment and Prevention of Opioid Use Disorder: Overview
• Treatment and Prevention of Opioid Use Disorder: Overview FAQ
• What You Should Know About the Opioid Crisis and How You Can Help

Articles

ATTC Messenger

• June 2018: Opioid Use Disorder and Buprenorphine Treatment
• May 2018: Opioid Misuse, Hepatitis C, and HIV: Hepatitis Awareness Month
• March 2018: The Evolution of Federal Drug Policy and Its Impacts on Treatment for Opioid Use Disorder
• September 2017: Recovery Oriented Systems of Care
• August 2017: The Opioid Epidemic in Rural Populations
• June 2017: Addiction Medicine: Physician Certification in New Sub-Speciality
• May 2017: Hepatitis Awareness Month: What Factors Help Patients Stay in Treatment?
• April 2017: Technology and Recovery
• March 2017: Providers' Clinical Support System
• January 2017: Shared Decision Making and Medication-Assisted Treatment
• Decemeber 2016: Project Echo: Expanding access to treatment for mental health and substance use disorders
• October 2016: Expanding medication-assisted treatment to native communities
• January 2016: ASAM National Practice Guideline
• December 2015: Developing and Testing an Opioid Risk Screening Tool for Trauma Centers
• September 2015: Addressing the Prescription Opioid and Heroin Crisis
• January 2015: Integration of SUD Services and Primary Care: The Role of the ATTC Network
• April 2014: Manaagement of Benzodiazepines in Medication-assisted Treatment
• July 2013: Prescription drug abuse and pain management
• September 2012: Medication-assisted Treatment Part 3
• August 2012: Medication-assisted Treatment Part 2
• July 2012: Medication-assisted Treatment Part 1

The Bridge

• Medication Assisted Treatment (volume 3, issue 2)
• Buprenorphine and Integration (volume 4, issue 3)

Addiction Science Made Easy (ASME)

• Buprenorphine vs. Methadone for Opioid Use Disorders: Long-term Outcomes
• Chronic pain elevates risk for opioid use during buprenorphine taper
• Chronic pain prevalent among patients with opioid use disorder
• Clonidine increases likelihood of abstinence in buprenorphine-maintained patients
• Clonidine maintenance prolongs opioid abstinence
• Extended-release naltrexone and buprenorphine-naloxone equally safe and effective: Outcomes from CTN-0051
• Extended-release naltrexone for treatment of opioid and alcohol use disorders in HIV Clinics
• High mortality among patients with opioid use disorder in general healthcare system
• Integrating buprenoprhine into formerly "drug-free" programs
• Is There a Role for Behavioral Interventions in Buprenorphine Treatment?
• Long-term bupronrophine/naloxone outcomes promising for prescription opioid users
• New Item Bank for Prescription Pain Medication Developed for PROMIS
• Prescription opioid registry protocol in integrated health system
• Prescription Opioid Treatment Study: What Have We Learned?
• Prescription Opioid Addiction Treatment Outcomes in Patients with Chronic Pain
• Primary Care-Based Models for Opioid Use Disorder Treatment
• Substance use disorders prevalent in adult primary care patients
• Web-based interventions not helpful for opioids
• X-Bot study to compare extended-release naltrexone to buprenorphine for opioid tx

ATTC/NIATx Service Improvement Blog

• Help for the Opioid Crisis: STR-Technical Assistance Available to States and Territories
• Get Naloxone Now: Everything You Need to Know to Save a Life
• 5 Things Dr. Dennis McCarty Wants You to Know about Treatment and Prevention of Opioid Use Disorder
• Everything You Need to Know About Medications for Treatment Opioid Use Disorders: SAMHSA TIP 63
• Responding To the Opiod Epidemic
• Shared Decision Making: Helping Prescribers Taper Opioid Prescribtions in Maine
• Taking Action to Address Opioid Misuse
• The Opioid Crisis: Community is Key to Address the Epidemic
• What do Med Students and Prescribers Need to Know About Opioid Use Disorders?

Page last updated 03/14/2018